MedTrace Logo

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT06827990 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-04-14

No results posted yet for this study

Summary

To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.

Conditions

  • Aortic Dissection

Interventions

DEVICE

GORE® Ascending Stent Graft (ASG device)

Endovascular aortic repair of the ascending aorta

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Eric Roselli, MD · The Cleveland Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-22
Primary Completion
2030-09-01
Completion
2031-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827990 on ClinicalTrials.gov